Dynamic42 interviewed by MDR

23. February 2021 In News

Dynamic42 interviewed by MDR

In the interview with MDR Thüringen, we answer many questions about our company, our vision and we reveal how we came up with the name “Dynamic42”. You can find the complete interview and the feature in the MDR Thüringen Journal here.

Press Release | Dynamic42 launches Tumor Microenvironment Kit to advance complex in vitro cancer research

Dynamic42 GmbH announces the market launch of its Tumor Microenvironment (TME) Kit. The new product enables the creation of perfused 3D tumor models that reproduce the complexity of the human tumor microenvironment.

Press Release | Ohio Lumex Named Exclusive U.S. Distributor for Dynamic42’s Advanced Organ-on-Chip Technology

Ohio Lumex, a recognized leader in analytical solutions, is proud to announce a new partnership with German biotechnology company Dynamic42. Effective immediately, Ohio Lumex will serve as the exclusive distributor of Dynamic42’s innovative organ-on-chip technology in the United States.

Press Release | Tumour-on-chip model supports preclinical drug development on pancreatic cancer

Dynamic42 and Heinrich Heine University have developed a tumour-on-a-chip model that replicates the microenvironment of pancreatic ductal adenocarcinoma (PDAC). This 3D model allows for realistic drug testing and could accelerate the development of personalized therapies.

All News